What distinguishes Kloxxado from the many other ways naloxone is delivered and why was it developed in the first place?

In the final episode of our 3-part series on antipsychotics, you’re going to find out whether these drugs have a class effect in mania, among other topics that inform practice.

We break down three main autism intervention approaches, and provide you with information that will help you improve on your abilities to recognize which particular autism intervention might be best for a specific patient.

A review of how an anesthetic agent turned into an antipsychotic, and how Bing Crosby lit a spark that would eventually lead psychiatrists to revise their entire diagnostic system.

An interview with Michael Poyurovsky, MD, on the paradoxical effects of antipsychotics in OCD and the many ways that OCD symptoms show up in schizophrenia.

Genetic testing is all the rage in psychiatry, but the test that might work best is the one that no one is talking about.

Both serotonin syndrome and neuroleptic malignant syndrome often present with muscle rigidity, hyperthermia, and altered mental status. Here's how to diagnose and treat them.

The Cures Act was a federal law passed in 2016 that included various mental health provisions. This law has significant implications on the way we share information with our patients and their families.

Is ketamine a glutamate antagonist or a spiritual kindler? Ketamine has two origin stories, each with its own understanding of how it treats depression. One came from the East, and one from the West, and after the Iron Curtain came down the two met face to face. Today, we tell that story.

Phase III clinical trials are beginning to roll out for psychedelic medications like like psilocybin and MDMA – also known as magic mushrooms and ecstasy. But this is not the first time these drugs have been used to treat mental illness, and today we take a dive into the clinical reports on psilocybin from half a century ago.